EUVIMEDEUVIMED entdecken
Crossref

Development of fast-dissolving sublingual nanofibers containing allergen and curcumin for immune response modulation in a mouse model of allergic rhinitis

Bahareh Ansari, Mohammad Reza Abbaspour, Ayda Estajy, Navideh Haghnavaz, Safoora Pordel, MohammadAli Rezaee, Saeideh Sadat Shobeiri, Malihe Moghadam, Maryam Hashemi, Mojtaba Sankian

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024

DOI: 10.1007/s00210-024-03139-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Bahareh Ansari und 9 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Nanofibers, Mice, Inbred BALB C, Rhinitis, Allergic, Ovalbumin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Mashhad University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Curcumin (CUR) has been considered a potential therapeutic agent for allergic reactions due to its antioxidant and anti-inflammatory activities. Nanofibers have attracted increasing attention in drug delivery. The aim of this study was to investigate the combined therapeutic effects of curcumin and allergen in nanofiber-based treatments in order to increase the effectiveness of sublingual immunotherapy (SLIT) efficacy in a mouse model of allergic rhinitis. Nanofibers containing CUR (1.25% and 2.5%) and ovalbumin 2% (OVA) as an allergen were prepared via electrospinning and characterized. BALB/c mice were sensitized with OVA to the induced allergic rhinitis model. SLIT with free and/or nanofibers was carried out. IL-4, INF-γ, and IgE serum levels were measured using ELISA. Splenocyte proliferation was evaluated by the MTT assay. Lung and nasal histological examinations and nasal lavage fluid (NALF) cell counting were carried out. Nanofibers containing 1.25% CUR and 2% OVA were chosen as the optimal formulations. SLIT treatment with the CUR and OVA nanofiber co-administration led to a significantly decreased serum IgE. Nanofiber containing 2.5 µg of CUR/mouse combined with OVA nanofiber showed a significant decrease in IL-4 and an increase in IFN-γ compared to other groups. NALF assessment showed a significant decrease in specific cell and eosinophil counts in the treated nanofiber groups. The histopathological results of NAL in the optimal formulations were near normal, with diminished cellular infiltration and inflammation. Our findings suggest that co-sublingual administration of allergen and CUR nanofibers can be considered as potential immunomodulatory agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanofibersMice, Inbred BALB CRhinitis, AllergicOvalbuminDisease Models, AnimalAllergensCurcuminImmunoglobulin ESublingual ImmunotherapyAnimalsFemaleMiceAdministration, SublingualInterferon-gammaInterleukin-4SpleenLung

Stichwörter der Autor:innen

AllergyCurcuminDrug deliveryImmunotherapyNanofibersSLIT

Substanzen

OvalbuminAllergensCurcuminImmunoglobulin EInterferon-gammaIl4 protein, mouseInterleukin-4

Autor:innen und Institutionen

  • Immunology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Medical Laboratory Sciences, Faculty of Paramedical, Kurdistan University of Medical Sciences, Sanandaj, Iran.
  • Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.
  • Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad, University of Medical Sciences, Mashhad, Iran. HashemiM@mums.ac.ir.

Förderung

  • Mashhad University of Medical Sciences

Zitieren

APA

Ansari, B., Abbaspour, M. R., Estajy, A., Haghnavaz, N., Pordel, S., Rezaee, M., Shobeiri, S. S., Moghadam, M., Hashemi, M., & Sankian, M. (2024). Development of fast-dissolving sublingual nanofibers containing allergen and curcumin for immune response modulation in a mouse model of allergic rhinitis. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03139-y

Vancouver

Ansari B, Abbaspour MR, Estajy A, Haghnavaz N, Pordel S, Rezaee M, et al. Development of fast-dissolving sublingual nanofibers containing allergen and curcumin for immune response modulation in a mouse model of allergic rhinitis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-024-03139-y

BibTeX
@article{Ansari2024,
  author = {Ansari, Bahareh and Abbaspour, Mohammad Reza and Estajy, Ayda and Haghnavaz, Navideh and Pordel, Safoora and Rezaee, MohammadAli and Shobeiri, Saeideh Sadat and Moghadam, Malihe and Hashemi, Maryam and Sankian, Mojtaba},
  title = {Development of fast-dissolving sublingual nanofibers containing allergen and curcumin for immune response modulation in a mouse model of allergic rhinitis},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  doi = {10.1007/s00210-024-03139-y}
}
Kostenlos starten →